Biohaven Ltd is headquartered in the British Virgin Islands and the US. It’s a biopharmaceutical company dedicated to developing innovative treatments in key therapeutic areas such as neuroscience, immunology and oncology. Its primary aim is to discover and advance new treatments for patients facing significant unmet medical needs globally.
Operating within the healthcare sector, Biohaven Ltd is advancing a diverse pipeline of potential treatments across various therapeutic modalities. It is advancing many late and early-stage drug development programs.
Stay up to date on the share price of BHVN by adding it to your eToro watchlist
This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.